A carregar...
Intravenous Alpha-1 Antitrypsin Therapy for Alpha-1 Antitrypsin Deficiency: The Current State of the Evidence
Alpha-1 antitrypsin deficiency (AATD) is a largely monogenetic disorder associated with a high risk for the development of chronic obstructive pulmonary disease (COPD) and cirrhosis. Intravenous alpha-1 antitrypsin (AAT) therapy has been available for the treatment of individuals with AATD and COPD...
Na minha lista:
| Publicado no: | Chronic Obstr Pulm Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
COPD Foundation Inc
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6373587/ https://ncbi.nlm.nih.gov/pubmed/30775428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.6.1.2017.0185 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|